https://www.vanityfair.com/news/2021/10/nih-admits-funding-risky-virus-research-in-wuhan
Don't forget the yanks funded Gain of function research in Wuhan... its a dark rabbit hole once you go down it...
Who really knows the reasoning behind it all..
planned?
Wouldn't put it pass them..
Just wish I could throw the kitchen sink at this... unfortunately sink has been replaced by a plastic bucket!
Beware conflicts of interest!
https://youtu.be/DC1h6l-eXJw
I will check out Indigos explanation...
Apart from that, I was also extremely impressed..
Once this ball starts to roll it'll gather momentum, setting us up nicely into next year. I'm sure, like most on here who've waited a while, an extra year or so is nothing...
Im looking forward to this time next year and hitting ATH's. FWIW I expect £1 territory by Xmas 22.
Around the 1hr 10min mark on the presentation .. Possible future dispute in regards royalties with Maersk.. Why would this be?
Under promise, over deliver...that's the way
Nm
This testing programme concludes the Proof-of-Concept work that was scheduled in Phase 1 of the Commercial Trial Agreement announced on 18 August 2020 and Quadrise and Greenfield are now in discussions regarding potential future trials and deployment of the technology to produce MSAR® and/or bioMSAR™ fuel at commercial scale.
Commercial scale! That's the one
This is the reason why... Evergrande! If it goes under, hold on to your hats..! Covid will be the least of our worries
https://www.google.com/amp/s/www.wsj.com/amp/articles/pop-goes-the-chinese-property-bubble-china-evergrande-group-xi-jinping-11631827034
Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results
Paris, France and Camberley, UK - 16 September 2021 - Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces the proposed accounting treatment of the ongoing DHSC dispute on its unaudited H1 2021 interim results for the six months ended 30 June 2021. The interim results are expected to be announced on 27 September 2021.
T here has been no further update to the announcement made at the time of the Company's full year results on 22 June 2021 , and subsequent half year update on 18 August 2021, in relation to the DHSC dispute. The accounting treatment of the DHSC revenue and costs in H1 2021, detailed below, does not change the Company's legal position or rights in relation to the dispute. The Company continues to work with its legal advisers to progress the dispute and believes it has strong grounds to assert its contractual rights .
The Company reiterates revenue guidance, excluding the disputed DHSC revenue, for the full year of approximately £100 million and underlying EBITDA margin of approximately 40%, as announced on 22 June 2021. However, the full year Group EBITDA margin could be materially affected by the outcome of the ongoing dispute with the DHSC and the write down of inventory as detailed below.
At the time of the Company's half year update on 18 August 2021, it was noted that £40.8 million of revenue in H1 2021 was in dispute with the DHSC. For the purposes of the interim results, the Company is required to apply the applicable accounting standards to the disputed revenues. The Board has therefore taken a conservative approach and decided that while the dispute with the DHSC remains unresolved the Company will not recognise the H1 2021 revenue of £40.8 million from the DHSC, in line with IFRS 15 accounting standard on revenue from contracts with customers. The remaining H1 2021 revenue of £54.0 million from non-DHSC sales remains unchanged.
In addition to not recognising the £40.8 million of DHSC sales in its interim results, the Company has prudently decided to recognise manufacturing costs of £6.9 million relating to these disputed sales.
The Company is also taking an exceptional one-off cost of £28.9m to write down inventory that the Company had built in anticipation of further DHSC demand and to terminate supply commitments with third parties in respect of this supply that are no longer required. This inventory build was Novacyt's direct response to support the UK Government's call for UK manufacturers to build manufacturing capacity and supply chain flexibility in response to the COVID-19 pandemic and was based on likely demand indicated by DHSC. The Company will continue to look for ways to use this inventory.
As announced on 18 August 2021, Novacyt continues to supply PROmate® COVID-19 tests to the NHS under the terms of a new contract aw
https://m.youtube.com/watch?v=D117mRHCCgk
MK making an appearance
Del Boy
"He who dares Rodders, he who dares!"
You know you can always sell Sal, and move on...
I think "somebody" knows what their doing... And has done their homework! 120 mil is picket change for a major..
And msar isn't "untested"... As I understand it was working wonderfully out at sea for the mighty Maersk..
Just out of interest, where are u seeing Qfi's breakthrough?
Free? Not a fan of free... Unless I have to buy it.
If that list is in size of importance , then being mentioned third (maybe wishful thinking!) is awesome..
Great find btw... Who else has a sense that something big has/is bubbling away over the pond..
Expect major news soon, me thinks
Look into ivermectin treating long covid...
Ivermectin is an anti viral, anti parasitic, anti inflammatory.. You could call it a wonder drug (Nobel prize for its inventor)... Unfortunately not a lot of money to be made from it, as its out of patent! Hence the radio silence on any mention of it...
Highlight his name, copy text and filter the ****.. Green box him/her!
It's become a pleasure reading this board again, lots of gr8 research.. GLA genuine holders.
Let's not spoil it by feeding shorters who magically appear once they've seen a rise.
https://amp.theguardian.com/world/2020/may/11/healthcare-firm-advised-by-owen-paterson-won-133m-coronavirus-testing-contract-unopposed
Disqusting really...
Str!ng them all up in Trafalgar Square I reckon
https://amp.theguardian.com/world/2020/may/11/healthcare-firm-advised-by-owen-paterson-won-133m-coronavirus-testing-contract-unopposed
When are we going to string these corrupt people up?!
Blood on their hands too... Disqusting